Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
- PMID: 15941725
- DOI: 10.1093/humupd/dmi013
Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
Abstract
The aetiology of polycystic ovary syndrome (PCOS) remains unknown. This familial syndrome is prevalent among reproductive-aged women and its inheritance indicates a dominant regulatory gene with incomplete penetrance. However, promising candidate genes have proven unreliable as markers for the PCOS phenotype. This lack of genetic linkage may represent both extreme heterogeneity of PCOS and difficulty in establishing a universally accepted PCOS diagnosis. Nevertheless, hyperandrogenism is one of the most consistently expressed PCOS traits. Animal models that mimic fetal androgen excess may thus provide unique insight into the origins of the PCOS syndrome. Many female mammals exposed to androgen excess in utero or during early post-natal life typically show masculinized and defeminized behaviour, ovulatory dysfunction and virilized genitalia, although behavioural and ovulatory dysfunction can coexist without virilized genitalia based upon the timing of androgen excess. One animal model shows particular relevance to PCOS: the prenatally androgenized female rhesus monkey. Females exposed to androgen excess early in gestation exhibit hyperandrogenism, oligomenorrhoea and enlarged, polyfollicular ovaries, in addition to LH hypersecretion, impaired embryo development, insulin resistance accompanying abdominal obesity, impaired insulin response to glucose and hyperlipidaemia. Female monkeys exposed to androgen excess late in gestation mimic these programmed changes, except for LH and insulin secretion defects. In utero androgen excess may thus variably perturb multiple organ system programming and thereby provide a single, fetal origin for a heterogeneous adult syndrome.
Similar articles
-
Development of polycystic ovary syndrome: involvement of genetic and environmental factors.Int J Androl. 2006 Feb;29(1):278-85; discussion 286-90. doi: 10.1111/j.1365-2605.2005.00623.x. Epub 2005 Dec 22. Int J Androl. 2006. PMID: 16390494 Review.
-
Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.J Clin Endocrinol Metab. 2006 May;91(5):1660-6. doi: 10.1210/jc.2005-2757. Epub 2006 Mar 7. J Clin Endocrinol Metab. 2006. PMID: 16522691 Review.
-
Polycystic ovary syndrome in adolescents.Int J Obes (Lond). 2008 Jul;32(7):1035-41. doi: 10.1038/ijo.2008.61. Epub 2008 May 6. Int J Obes (Lond). 2008. PMID: 18458678 Review.
-
Androgen circle of polycystic ovary syndrome.Hum Reprod. 2009 Jul;24(7):1548-55. doi: 10.1093/humrep/dep049. Epub 2009 Mar 11. Hum Reprod. 2009. PMID: 19279033
-
Adult polycystic ovary syndrome begins in childhood.Best Pract Res Clin Endocrinol Metab. 2002 Jun;16(2):263-72. doi: 10.1053/beem.2002.0203. Best Pract Res Clin Endocrinol Metab. 2002. PMID: 12064892 Review.
Cited by
-
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Endocr Rev. 2012 Dec;33(6):981-1030. doi: 10.1210/er.2011-1034. Epub 2012 Oct 12. Endocr Rev. 2012. PMID: 23065822 Free PMC article. Review.
-
Pubertal development among girls with classical congenital adrenal hyperplasia initiated on treatment at different ages.Indian J Endocrinol Metab. 2012 Jul;16(4):599-603. doi: 10.4103/2230-8210.98018. Indian J Endocrinol Metab. 2012. PMID: 22837923 Free PMC article.
-
Effects of perinatal testosterone on infant health, mother-infant interactions, and infant development.Biol Res Nurs. 2014 Apr;16(2):228-36. doi: 10.1177/1099800413486340. Epub 2013 May 2. Biol Res Nurs. 2014. PMID: 23639953 Free PMC article.
-
Translational Insight Into Polycystic Ovary Syndrome (PCOS) From Female Monkeys with PCOS-like Traits.Curr Pharm Des. 2016;22(36):5625-5633. doi: 10.2174/1381612822666160715133437. Curr Pharm Des. 2016. PMID: 27426126 Free PMC article. Review.
-
Gallic acid reverses ovarian disturbances in mice with letrozole-induced PCOS via modulating Adipo R1 expression.Toxicol Rep. 2022 Oct 20;9:1938-1949. doi: 10.1016/j.toxrep.2022.10.009. eCollection 2022. Toxicol Rep. 2022. PMID: 36518462 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical